Search details
1.
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.
Cell
; 172(3): 578-589.e17, 2018 01 25.
Article
in English
| MEDLINE | ID: mdl-29373830
2.
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors.
Proc Natl Acad Sci U S A
; 109(45): 18281-9, 2012 Nov 06.
Article
in English
| MEDLINE | ID: mdl-22988103
3.
Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.
Bioorg Med Chem Lett
; 21(4): 1270-4, 2011 Feb 15.
Article
in English
| MEDLINE | ID: mdl-21269826
4.
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Clin Cancer Res
; 14(22): 7272-83, 2008 Nov 15.
Article
in English
| MEDLINE | ID: mdl-19010843
5.
Spatial frequency domain imaging: a quantitative, noninvasive tool for in vivo monitoring of burn wound and skin graft healing.
J Biomed Opt
; 24(7): 1-9, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31313538
6.
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.
Cancer Discov
; 6(3): 316-29, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26739882
7.
Substrate-specific conformational regulation of the receptor tyrosine kinase VEGFR2 catalytic domain.
ACS Chem Biol
; 8(5): 978-86, 2013 May 17.
Article
in English
| MEDLINE | ID: mdl-23441851
8.
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.
ACS Med Chem Lett
; 2(11): 809-13, 2011 Nov 10.
Article
in English
| MEDLINE | ID: mdl-24900269
9.
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.
Cancer Res
; 71(4): 1362-73, 2011 Feb 15.
Article
in English
| MEDLINE | ID: mdl-21212415
10.
Dual functional monoclonal antibody PF-04605412 targets integrin alpha5beta1 and elicits potent antibody-dependent cellular cytotoxicity.
Cancer Res
; 70(24): 10243-54, 2010 Dec 15.
Article
in English
| MEDLINE | ID: mdl-21159645
Results
1 -
10
de 10
1
Next >
>>